Navigation Links
Poniard Pharmaceuticals Presents Final Results of Phase 1 Study of Oral Picoplatin Demonstrating Bioavailability
Date:4/21/2009

atinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. It is being studied in multiple cancer indications, treatment combinations and by two routes of administration.

Poniard is currently evaluating the efficacy and safety of picoplatin in SCLC in the pivotal Phase 3 SPEAR (Study of Picoplatin Efficacy After Relapse) trial, which is being conducted under a Special Protocol Assessment agreement with the U.S. Food and Drug Administration. The Company reached its enrollment target in this international, multi-center, randomized, controlled trial in March 2009. Poniard is also evaluating picoplatin in two Phase 2 clinical trials -- one in patients with metastatic CRC and the other in patients with castration-resistant (or hormone-refractory) prostate cancer.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's results of clinical trials, business objectives and strategic goals, drug development plans, the potential safety and efficacy of its products in development and commercialization strategy. The Company's actual results may differ materially from those indicated in these forward-looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of clinical testing; the receipt and timing of FDA and other required regulatory approvals; the market's acceptance of the Company's proposed products; the Company's anticipated operating l
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Poniard Pharmaceuticals Announces Upcoming Conference Participation
2. Poniard Pharmaceuticals Reports Second Quarter 2008 Financial Results and Corporate Update
3. Poniard Pharmaceuticals Reports Third Quarter 2008 Financial Results and Corporate Update
4. Poniard Pharmaceuticals Provides 2009 Clinical Data Goals for Picoplatin
5. Poniard Pharmaceuticals Announces Appointment of Greg Weaver as Chief Financial Officer
6. Poniard Pharmaceuticals Receives Going Concern Qualification
7. Poniard Pharmaceuticals to Present at Needham & Companys Cancer Therapeutics: Today & Tomorrow Conference
8. Poniard Pharmaceuticals to Focus Company Resources on Late-Stage Oncology Candidate Picoplatin Through Realignment of Research Organization
9. Poniard Announces Publication of Results of Picoplatin Phase 2 Study in Journal of Clinical Oncology
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 A new ... of experience and person-centeredness in the long-term care environment ... action across the continuum. The paper, “The Power of ... engages perspectives and practices of the patient, resident and ...
(Date:1/22/2015)... 2015 Carinsurancesavings.biz has released a new blog ... dismemberment insurance . , Purchasing an accidental death and ... advantageous. This type of rider provides benefits if the insured ... considered a lesser form of life insurance. , AD&D ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne ... highest annual revenues in the past three years. Today, the ... dresses. , According to the sales manager of the company, ... them in 2015. This point can be reflected on the ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... an effort to further promote visibility and adoption of the ... made AMA journals available via its subscription services, EBSCO will ... , Long known as both a subscription agency ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Lower-Auto-Insurance.com has released a ... kit in a car for reducing the costs of an ... will also be able to get lower prices for their vehicle ... an important role in determining policy costs. Because of this, ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Accidental Death and Dismemberment Insurance Can Be Purchased at Low Prices Online 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... conference explores medical applications of mid-infrared laser technologies, ... for diabetes, cancer diagnostics, and environmental health monitoring. ... interest and addresses market impact. The event is ... Mid-InfraRed Technologies for Health and the Environment (MIRTHE) ...
... News) -- Smokers have heart attacks earlier in life than ... suffer complications after a heart attack, according to a new ... the University of Michigan Medical Center from 1999 through 2006 ... patients were current smokers. Male smokers were nine years ...
... Physical Journal E (EPJE), a German scientist constructed a ... soft matter that can be applied in food and cosmetics ... for Material Physics in Space in Cologne, Germany, evaluated the ... a solid material made of a metallic melt with a ...
... by Johns Hopkins researchers, say they may have found ... disease (AD) will lose cognitive function by looking at ... finding, they say, could provide useful information to families ... this heartbreaking and incurable neurodegenerative disorder. Past research ...
... Oct. 4 (HealthDay News) -- Heart patients who have stenting procedures ... are released the same day as if they are sent home ... patients the same day] wasn,t associated with any increased risk at ... appearing in the Oct. 5 issue of the Journal of ...
... Oct. 4 (HealthDay News) --, People may be learning while ... new study suggests. Although the effects on memory ... researchers said their findings reinforce the need for a good ... getting, according to the U.S. National Sleep Foundation. "We ...
Cached Medicine News:Health News:Unlocking jams in fluid materials 2Health News:Blood tests may hold clues to pace of Alzheimer's disease progression 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 2Health News:Overnight Stay May Not Be Necessary for Stenting: Study 3
(Date:1/23/2015)... Jan. 23, 2015  MedScope ( www.medscope.org ), the leading ... a 2015 Connected World magazine Connected World ... (mPERS), that can be used anywhere, anytime. The nomination ... In nominating MedScope, Landon Garner , ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
(Date:1/23/2015)...  Now available for sale, The Armor1 Ankle Roll Guard is ... sprains by cushioning the ankle from an inversion or ... outside of any shoe type and allows the user ... protection against sprains. With customers in physical therapy, podiatry, ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2The Armor1 Ankle Roll Guard is the New Breakthrough Solution for Ankle Sprain Prevention! 2
... FRANKLIN, Mass., March 21, 2011 Echo Therapeutics, Inc. ... developing its needle-free Symphony™ tCGM System as a non-invasive, ... Prelude™ SkinPrep System for transdermal drug delivery, today announced ... Annual Report on Form 10-K is available through Echo,s ...
... 2011 NeuroFocus unveiled the first dry, wireless ... full brain today at the 75th Annual Advertising ... Marquis in New York.  Developed over the last ... leapfrogging current neurological testing methods.  For the first ...
Cached Medicine Technology:Echo Therapeutics Announces 2010 Financial Results 2Echo Therapeutics Announces 2010 Financial Results 3Echo Therapeutics Announces 2010 Financial Results 4NeuroFocus Announces World's First Wireless Full-Brain EEG Measurement Headset: Mynd™ 2NeuroFocus Announces World's First Wireless Full-Brain EEG Measurement Headset: Mynd™ 3NeuroFocus Announces World's First Wireless Full-Brain EEG Measurement Headset: Mynd™ 4
Assists in early recognition of changes in the macula and foveal areas., ,Only 6 patient responses required for diagnosis of functional disturbances, from small scotoma to distortions. Full instructi...
Comes complete with its own case. A unique integrated design with no need for two separate bars., ,Optical surfaces are recessed for optimum protection. Extensive prism power 1,2,3,4,6,8,10,15,20...
... Interventions, like all important missions, ... guide you to your destination. ... you this dependability. So you ... the intervention and not have ...
Designed for young and disabled children but equally suitable for older children and adults., ,Optional 6/60 to 6/24 booklet available for patients who fail standard screening test and require fu...
Medicine Products: